These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
946 related articles for article (PubMed ID: 32204513)
1. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells. Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK Cells; 2020 Mar; 9(3):. PubMed ID: 32204513 [TBL] [Abstract][Full Text] [Related]
2. Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer. Ono K; Sogawa C; Kawai H; Tran MT; Taha EA; Lu Y; Oo MW; Okusha Y; Okamura H; Ibaragi S; Takigawa M; Kozaki KI; Nagatsuka H; Sasaki A; Okamoto K; Calderwood SK; Eguchi T J Extracell Vesicles; 2020 May; 9(1):1769373. PubMed ID: 33144925 [TBL] [Abstract][Full Text] [Related]
3. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer. Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988 [TBL] [Abstract][Full Text] [Related]
4. HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. Ono K; Eguchi T; Sogawa C; Calderwood SK; Futagawa J; Kasai T; Seno M; Okamoto K; Sasaki A; Kozaki KI J Cell Biochem; 2018 Sep; 119(9):7350-7362. PubMed ID: 29768689 [TBL] [Abstract][Full Text] [Related]
5. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Gray PJ; Stevenson MA; Calderwood SK Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825 [TBL] [Abstract][Full Text] [Related]
6. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Ota A; Zhang J; Ping P; Han J; Wang Y Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663 [TBL] [Abstract][Full Text] [Related]
7. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening. He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254 [TBL] [Abstract][Full Text] [Related]
8. Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Taha EA; Ono K; Eguchi T Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533245 [TBL] [Abstract][Full Text] [Related]
9. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning. Smith JR; Workman P Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013 [TBL] [Abstract][Full Text] [Related]
10. Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth. Wu F; Peacock SO; Rao S; Lemmon SK; Burnstein KL J Biol Chem; 2013 Feb; 288(8):5463-74. PubMed ID: 23281476 [TBL] [Abstract][Full Text] [Related]
11. Cdc37 as a Co-chaperone to Hsp90. Prince TL; Lang BJ; Okusha Y; Eguchi T; Calderwood SK Subcell Biochem; 2023; 101():141-158. PubMed ID: 36520306 [TBL] [Abstract][Full Text] [Related]
12. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites. Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315 [TBL] [Abstract][Full Text] [Related]
13. Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion. El Hamidieh A; Grammatikakis N; Patsavoudi E PLoS One; 2012; 7(8):e42722. PubMed ID: 22912728 [TBL] [Abstract][Full Text] [Related]
14. Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression. Ono K; Eguchi T Methods Mol Biol; 2023; 2693():141-161. PubMed ID: 37540433 [TBL] [Abstract][Full Text] [Related]
15. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666 [TBL] [Abstract][Full Text] [Related]
16. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors. Smith JR; Clarke PA; de Billy E; Workman P Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700 [TBL] [Abstract][Full Text] [Related]
17. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A. Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561 [TBL] [Abstract][Full Text] [Related]
18. Cdc37 as a co-chaperone to Hsp90. Calderwood SK Subcell Biochem; 2015; 78():103-12. PubMed ID: 25487018 [TBL] [Abstract][Full Text] [Related]
19. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins. Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914 [TBL] [Abstract][Full Text] [Related]
20. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins. Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]